## 重點: 

- Of the 507 patients who underwent screening, 340 were in the intention-to-treat population, with 226 assigned to the thrombectomy group and 114 to the control group.
- Intravenous thrombolysis was used in 31% of the patients in the thrombectomy group and in 34% of those in the control group.
- Good functional status at 90 days occurred in 104 patients (46%) in the thrombectomy group and in 26 (23%) in the control group (adjusted rate ratio, 2.06; 95% confidence interval [CI], 1.46 to 2. P<0.001).
- Symptomatic intracranial hemorrhage occurred in 12 patients (5%) in the thrombectomy group and in none in the control group.
- Results for the secondary clinical and imaging outcomes were generally in the same direction as those for the primary outcome.
- Mortality at 90 days was 37% in the thrombectomy group and 55% in the control group (adjusted risk ratio, 0.66; 95% CI, 0.52 to 0.82).
- Procedural complications occurred in 14% of the patients in the thrombectomy group, including one death due to arterial perforation.

